Vicarious Surgical Inc (NYSE:RBOT) CTO Sammy Khalifa Sells 2,946 Shares

Vicarious Surgical Inc (NYSE:RBOTGet Rating) CTO Sammy Khalifa sold 2,946 shares of the company’s stock in a transaction on Wednesday, September 21st. The stock was sold at an average price of $3.89, for a total value of $11,459.94. Following the sale, the chief technology officer now directly owns 1,019,332 shares in the company, valued at approximately $3,965,201.48. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Sammy Khalifa also recently made the following trade(s):

  • On Thursday, September 15th, Sammy Khalifa sold 4,551 shares of Vicarious Surgical stock. The shares were sold at an average price of $4.17, for a total value of $18,977.67.
  • On Monday, August 29th, Sammy Khalifa sold 4,097 shares of Vicarious Surgical stock. The shares were sold at an average price of $3.83, for a total value of $15,691.51.
  • On Thursday, August 25th, Sammy Khalifa sold 3,072 shares of Vicarious Surgical stock. The shares were sold at an average price of $4.13, for a total value of $12,687.36.
  • On Tuesday, August 23rd, Sammy Khalifa sold 1,521 shares of Vicarious Surgical stock. The shares were sold at an average price of $3.96, for a total value of $6,023.16.
  • On Thursday, July 14th, Sammy Khalifa sold 6,862 shares of Vicarious Surgical stock. The shares were sold at an average price of $3.19, for a total transaction of $21,889.78.

Vicarious Surgical Trading Down 2.9 %

Shares of RBOT traded down $0.11 during mid-day trading on Thursday, hitting $3.73. 146,436 shares of the company’s stock were exchanged, compared to its average volume of 349,472. Vicarious Surgical Inc has a fifty-two week low of $2.82 and a fifty-two week high of $15.40. The firm has a market capitalization of $454.00 million, a P/E ratio of 18.65 and a beta of 0.75. The business’s 50 day moving average is $4.05 and its two-hundred day moving average is $4.15.

Vicarious Surgical (NYSE:RBOTGet Rating) last announced its quarterly earnings data on Monday, August 8th. The company reported ($0.16) EPS for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.02). On average, equities research analysts forecast that Vicarious Surgical Inc will post -0.62 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the stock. Advisor Group Holdings Inc. increased its holdings in Vicarious Surgical by 218.5% in the fourth quarter. Advisor Group Holdings Inc. now owns 5,893 shares of the company’s stock valued at $63,000 after buying an additional 4,043 shares in the last quarter. Cubist Systematic Strategies LLC increased its holdings in Vicarious Surgical by 7.4% in the second quarter. Cubist Systematic Strategies LLC now owns 61,496 shares of the company’s stock valued at $181,000 after buying an additional 4,235 shares in the last quarter. Charles Schwab Investment Management Inc. increased its holdings in Vicarious Surgical by 2.5% in the first quarter. Charles Schwab Investment Management Inc. now owns 177,835 shares of the company’s stock valued at $900,000 after buying an additional 4,391 shares in the last quarter. DDD Partners LLC increased its holdings in Vicarious Surgical by 0.5% in the second quarter. DDD Partners LLC now owns 1,037,508 shares of the company’s stock valued at $3,050,000 after buying an additional 4,928 shares in the last quarter. Finally, Rockefeller Capital Management L.P. increased its holdings in Vicarious Surgical by 125.0% in the fourth quarter. Rockefeller Capital Management L.P. now owns 9,000 shares of the company’s stock valued at $95,000 after buying an additional 5,000 shares in the last quarter. 51.79% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, BTIG Research decreased their price objective on shares of Vicarious Surgical from $8.00 to $7.00 and set a “buy” rating for the company in a research note on Monday, July 18th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $11.60.

Vicarious Surgical Company Profile

(Get Rating)

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Featured Articles

Insider Buying and Selling by Quarter for Vicarious Surgical (NYSE:RBOT)

Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.